1. Home
  2. XOMA vs GNE Comparison

XOMA vs GNE Comparison

Compare XOMA & GNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • GNE
  • Stock Information
  • Founded
  • XOMA 1981
  • GNE 2011
  • Country
  • XOMA United States
  • GNE United States
  • Employees
  • XOMA N/A
  • GNE N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • GNE Power Generation
  • Sector
  • XOMA Health Care
  • GNE Utilities
  • Exchange
  • XOMA Nasdaq
  • GNE Nasdaq
  • Market Cap
  • XOMA 457.6M
  • GNE 407.6M
  • IPO Year
  • XOMA N/A
  • GNE N/A
  • Fundamental
  • Price
  • XOMA $33.33
  • GNE $14.86
  • Analyst Decision
  • XOMA Strong Buy
  • GNE
  • Analyst Count
  • XOMA 2
  • GNE 0
  • Target Price
  • XOMA $69.50
  • GNE N/A
  • AVG Volume (30 Days)
  • XOMA 43.0K
  • GNE 109.6K
  • Earning Date
  • XOMA 11-05-2025
  • GNE 11-03-2025
  • Dividend Yield
  • XOMA N/A
  • GNE 2.02%
  • EPS Growth
  • XOMA N/A
  • GNE 49.43
  • EPS
  • XOMA N/A
  • GNE 0.18
  • Revenue
  • XOMA $44,952,000.00
  • GNE $483,284,000.00
  • Revenue This Year
  • XOMA $88.91
  • GNE $14.60
  • Revenue Next Year
  • XOMA $13.80
  • GNE $8.64
  • P/E Ratio
  • XOMA N/A
  • GNE $53.50
  • Revenue Growth
  • XOMA 194.98
  • GNE 13.12
  • 52 Week Low
  • XOMA $18.35
  • GNE $13.05
  • 52 Week High
  • XOMA $39.92
  • GNE $28.47
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 44.97
  • GNE 43.60
  • Support Level
  • XOMA $31.97
  • GNE $13.56
  • Resistance Level
  • XOMA $34.71
  • GNE $15.13
  • Average True Range (ATR)
  • XOMA 1.43
  • GNE 0.57
  • MACD
  • XOMA -0.09
  • GNE -0.04
  • Stochastic Oscillator
  • XOMA 44.06
  • GNE 56.90

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About GNE Genie Energy Ltd. Class B Stock

Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.

Share on Social Networks: